Search Results - "GENEIX, J"

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines by GINESTIER, C, ADELAÏDE, J, JACQUEMIER, J, VIENS, P, BIRNBAUM, D, GONCALVES, A, REPELLINI, L, SIRCOULOMB, F, LETESSIER, A, FINETTI, P, GENEIX, J, CHARAFE -JAUFFRET, E, BERTUCCI, F

“…Breast cancers that overexpress the ERBB2 tyrosine kinase receptor may be treated with the recombinant humanized monoclonal anti-ERBB2 antibody trastuzumab…”
Get full text

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer by LETESSIER, A, GARRIDO-URBANI, S, VIENS, P, CHARAFE -JAUFFRET, E, JACQUEMIER, J, BIRNBAUM, D, LOPEZ, M, CHAFFANET, M, GINESTIER, C, FOURNIER, G, ESTERNI, B, MONVILLE, F, ADELAÏDE, J, GENEIX, J, XERRI, L, DUBREUIL, P

“…Common fragile sites (CFSs) are regions of chromosomal break that may play a role in oncogenesis. The most frequent alteration occurs at FRA3B, within the FHIT…”
Get full text

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis by Jacquemier, Jocelyne D., Penault-Llorca, Frederique M., Bertucci, Francois, Sun, Zhen Z., Houvenaeghel, Gilles F., Geneix, Jeanine A., Puig, Brigitte D., Bardou, Valerie Jeanne H., Hassoun, Jacques A., Birnbaum, Daniel, Viens, Patrice J.

“…It has now been clearly established that quantitative immunohistochemical methods applied to tumour angiogenesis under suitable quality control conditions are…”
Get full text

Comparative multi-methodological measurement of ERBB2 status in breast cancer by Ginestier, Christophe, Charafe-Jauffret, Emmanuelle, Penault-Llorca, Frédérique, Geneix, Jeannine, Adélaïde, José, Chaffanet, Max, Mozziconacci, Marie-Joëlle, Hassoun, Jacques, Viens, Patrice, Birnbaum, Daniel, Jacquemier, Jocelyne

“…The ERBB2 transmembrane tyrosine kinase receptor is both a prognostic marker and a therapeutic target in breast cancer. Accurate determination of ERBB2 status…”
Get full text

Integrated Profiling of Basal and Luminal Breast Cancers by ADELAÏDE, José, FINETTI, Pascal, SCHOENMAKERS, Eric, VIENS, Patrice, JACQUEMIER, Jocelyne, BIRNBAUM, Daniel, BERTUCCI, Francois, CHAFFANET, Max, BEKHOUCHE, Ismahane, REPELLINI, Laetitia, GENEIX, Jeannine, SIRCOULOMB, Fabrice, CHARAFE-JAUFFRET, Emmanuelle, CERVERA, Nathalie, DESPLANS, Jérome, PARZY, Daniel

“…Basal and luminal are two molecular subtypes of breast cancer with opposite histoclinical features. We report a combined, high-resolution analysis of genome…”
Get full text

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis by JACQUEMIER, Jocelyne, GINESTIER, Christophe, MARANINCHI, Dominique, VIENS, Patrice, BIRNBAUM, Daniel, BERTUCCI, Francois, ROUGEMONT, Jacques, BARDOU, Valérie-Jeanne, CHARAFE-JAUFFRET, Emmanuelle, GENEIX, Jeannine, ADELAÏDE, José, KOKI, Alane, HOUVENAEGHEL, Gilles, HASSOUN, Jacques

“…Breast cancer is a heterogeneous disease whose evolution is difficult to predict by using classic histoclinical prognostic factors. Prognostic classification…”
Get full text

Typical medullary breast carcinomas have a basal/myoepithelial phenotype by Jacquemier, Jocelyne, Padovani, Laetitia, Rabayrol, Laetitia, Lakhani, Sunil R, Penault-Llorca, Frédérique, Denoux, Yves, Fiche, Maryse, Figueiro, Paulo, Maisongrosse, Véronique, Ledoussal, Viviane, Martinez Penuela, Jose, Udvarhely, Nora, El Makdissi, George, Ginestier, Christophe, Geneix, Jeannine, Charafe-Jauffret, Emmanuelle, Xerri, Luc, Eisinger, François, Birnbaum, Daniel, Sobol, Hagay

“…Medullary breast cancer (MBC) is a rare, diagnostically difficult, pathological subtype. Despite being high grade, it has a good prognosis. MBC patients have…”
Get full text

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature' by Charafe-Jauffret, Emmanuelle, Tarpin, Carole, Bardou, Valérie-Jeanne, Bertucci, François, Ginestier, Christophe, Braud, Anne-Chantal, Puig, Brigitte, Geneix, Jeannine, Hassoun, Jacques, Birnbaum, Daniel, Jacquemier, Jocelyne, Viens, Patrice

“…Inflammatory breast cancer (IBC) is a rare but very aggressive form of breast cancer. Its definition is based on clinical criteria, but a molecular definition…”
Get full text

Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor Markers by Ginestier, Christophe, Charafe-Jauffret, Emmanuelle, Bertucci, François, Eisinger, François, Geneix, Jeannine, Bechlian, Didier, Conte, Nathalie, Adélaïde, José, Toiron, Yves, Nguyen, Catherine, Viens, Patrice, Mozziconacci, Marie-Joelle, Houlgatte, Rémi, Birnbaum, Daniel, Jacquemier, Jocelyne

“…Emerging high-throughput screening technologies are rapidly providing opportunities to identify new diagnostic and prognostic markers and new therapeutic…”
Get full text

Identification and validation of an ERBB2 gene expression signature in breast cancers by BERTUCCI, Francois, BORIE, Nathalie, HERMITTE, Fabienne, HASSOUN, Jacques, DEBONO, Stéphane, VIENS, Patrice, FERT, Vincent, JACQUEMIER, Jocelyne, BIRNBAUM, Daniel, GINESTIER, Christophe, GROULET, Agnès, CHARAFE-JAUFFRET, Emmanuelle, ADELAÏDE, José, GENEIX, Jeannine, BACHELART, Loïc, FINETTI, Pascal, KOKI, Alane

“…ERBB2 is a transmembrane tyrosine kinase receptor encoded by a gene located in chromosome region 17q12. Overexpression of ERBB2, generally by way of gene…”
Get full text

WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type by UGOLINI, Francoise, CHARAFE-JAUFFRET, Emmanuelle, PEBUSQUE, Marie-Josèphe, BARDOU, Valérie-Jeanne, GENEIX, Jeannine, ADELAÏDE, José, LABAT-MOLEUR, Francoise, PENAULT-LLORCA, Frédérique, LONGY, Michel, JACQUEMIER, Jocelyne, BIRNBAUM, Daniel

“…Secreted Frizzled-related protein 1 (SFRP1) encodes a member of a protein family that contains a cysteine-rich domain similar to the WNT-binding site of…”
Get full text

Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators by CONTE, Nathalie, CHARAFE-JAUFFRET, Emmanuelle, DELAVAL, Bénédicte, ADELAÏDE, José, GINESTIER, Christophe, GENEIX, Jeannine, ISNARDON, Daniel, JACQUEMIER, Jocelyne, BIRNBAUM, Daniel

“…The three human TACC genes encode a family of proteins that are suspected to play a role in carcinogenesis. Their function is not precisely known; a Xenopus…”
Get full text

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer by Letessier, A, Garrido-Urbani, S, Ginestier, C, Fournier, G, Esterni, B, Monville, F, Adelaide, J, Geneix, J, Xerri, L, Dubreuil, P, Viens, P, Charafe-Jauffret, E, Jacquemier, J, Birnbaum, D, Lopez, M, Chaffanet, M

“…Common fragile sites (CFSs) are regions of chromosomal break that may play a role in oncogenesis. The most frequent alteration occurs at FRA3B, within the FHIT…”
Get full text

Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer by Ginestier, Christophe, Bardou, Valérie‐Jeanne, Popovici, Cornel, Charafe‐Jauffret, Emmanuelle, Bertucci, François, Geneix, Jeannine, Adélaïde, José, Chaffanet, Max, Hassoun, Jacques, Viens, Patrice, Jacquemier, Jocelyne, Birnbaum, Daniel

“…The FHIT tumor suppressor gene, which encompasses the fragile site FRA3B at 3p14.2, is altered frequently in many types of human cancers. To determine its…”
Get full text

Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8 by Kerangueven, F, Essioux, L, Dib, A, Noguchi, T, Allione, F, Geneix, J, Longy, M, Lidereau, R, Eisinger, F, Pébusque, M J

“…We have analysed losses of heterozygosity (LOH) at eight markers from the p12-p22 region of human chromosome 8 in a panel of 113 breast tumors. LOH were…”
Get more information

Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells by Charafe-Jauffret, Emmanuelle, Moulin, Jean-François, Ginestier, Christophe, Bechlian, Didier, Conte, Nathalie, Geneix, Jeannine, Adélaïde, José, Noguchi, Tetsuro, Hassoun, Jacques, Jacquemier, Jocelyne, Birnbaum, Daniel

“…Alterations of chromosomal region 8p11-21 are very frequent in human cancers, and especially in breast cancer; yet, most of the genes involved have not been…”
Get more information

Prognosis of breast‐carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular‐endothelial‐growth‐factor receptor 3 by Jacquemier, Jocelyne, Mathoulin‐Portier, Marie‐Pierre, Valtola, Reija, Charafe‐Jauffret, Emmanuelle, Geneix, Jeannine, Houvenaeghel, Gilles, Puig, Brigitte, Bardou, Valérie‐Jeanne, Hassoun, Jacques, Viens, Patrice, Birnbaum, Daniel

“…Very few studies have yet addressed the question of the existence and role of lymphagenesis in tumor growth; it is generally overshadowed by the greater…”
Get full text

Chromosome region 8p11-p21: Refined mapping and molecular alterations in breast cancer by Adélaïde, José, Chaffanet, Max, Imbert, Alexandra, Allione, Florence, Geneix, Jeanine, Popovici, Cornel, van Alewijk, Dirk, Trapman, Jan, Zeillinger, Robert, Børresen-Dale, Anne-Lise, Lidereau, Rosette, Birnbaum, Daniel, Pébusque, Marie-Josèphe

“…Several genes, most of them unknown, of the short arm of chromosome 8 are involved in malignant diseases. Numerous studies have implicated a portion of the…”
Get full text

Tissue microarrays a powerful tool in transfer and quality control in oncology by Jacquemier, Jocelyne, Ginestier, Christophe, Bertucci, François, Jauffret, Emmanuelle Charafe, Geneix, Jeanine, Birnbaum, Daniel

“…The progress in the knowledge of molecular genetics and the availability of high-throughput technologies offer the opportunity to identify new diagnostic and…”
Get full text

Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists by Jacquemier, Jocelyne, Ginestier, Christophe, Charafe-Jauffret, Emmanuelle, Bertucci, François, Bege, Thierry, Geneix, Jeanine, Birnbaum, Daniel

“…Progress in the knowledge of molecular genetics and availability of high-throughput technologies offer the opportunity to identify new diagnostic and…”
Get more information